title: Reply to myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: analysis of persistent and new-onset cytopenia.
authors.affiliation: Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
authors.forename: Paolo
authors.initials: P
authors.lastname: Strati
authors.forename: Susan
authors.initials: S
authors.lastname: O'Brien
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects*; D007167:Immunotherapy / Q000009:adverse effects*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000628:therapy*; D008297:Male; D010198:Pancytopenia / Q000139:chemically induced*